# SGLT Inhibitors Versus DDP4 Inhibitors and Prostate in Patient With Diabetes

> **NCT06148259** · NA · COMPLETED · sponsor: **Kasr El Aini Hospital** · enrollment: 57 (actual)

## Conditions studied

- Diabetes Mellitus
- Prostatic Hyperplasia

## Interventions

- **OTHER:** International prostate symptom score
- **DIAGNOSTIC_TEST:** Assessment of prostate volume
- **OTHER:** Pittsburgh sleep quality Index
- **DIAGNOSTIC_TEST:** Glycated hemoglobin

## Key facts

- **NCT ID:** NCT06148259
- **Lead sponsor:** Kasr El Aini Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-12
- **Primary completion:** 2022-09-13
- **Final completion:** 2022-09-13
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2023-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06148259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06148259, "SGLT Inhibitors Versus DDP4 Inhibitors and Prostate in Patient With Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06148259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*